Genomic Health (GHDX) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free GHDX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Genomic Health Short Interest DataCurrent Short Volume1,340,000 sharesPrevious Short Volume1,380,000 sharesChange Vs. Previous Month-2.90%Dollar Volume Sold Short$95.61 millionShort Interest Ratio / Days to Cover2.2Last Record DateOctober 15, 2019Outstanding Shares37,590,000 sharesFloat Size37,020,000 sharesShort Percent of Float3.62%Today's Trading Volume0 sharesAverage Trading Volume1,049,573 sharesToday's Volume Vs. Average0% Short Selling Genomic Health ? Sign up to receive the latest short interest report for Genomic Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGHDX Short Interest Over TimeGHDX Days to Cover Over TimeGHDX Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Genomic Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20191,340,000 shares $95.61 million -2.9%3.6%2.2 $71.35 GHDX Short Interest - Frequently Asked Questions What is Genomic Health's current short interest? Short interest is the volume of Genomic Health shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 1,340,000 shares of GHDX short. 3.62% of Genomic Health's shares are currently sold short. Learn More on Genomic Health's current short interest. What is a good short interest ratio for Genomic Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GHDX shares currently have a short interest ratio of 2.0. Learn More on Genomic Health's short interest ratio. What is a good short interest percentage for Genomic Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.62% of Genomic Health's floating shares are currently sold short. Is Genomic Health's short interest increasing or decreasing? Genomic Health saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 1,340,000 shares, a drop of 2.9% from the previous total of 1,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genomic Health's float size? Genomic Health currently has issued a total of 37,590,000 shares. Some of Genomic Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genomic Health currently has a public float of 37,020,000 shares. How does Genomic Health's short interest compare to its competitors? 3.62% of Genomic Health's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Genomic Health: Guardant Health, Inc. (6.28%), RadNet, Inc. (4.32%), Fortrea Holdings Inc. (5.21%), Veracyte, Inc. (4.85%), Viridian Therapeutics, Inc. (15.09%), Fulgent Genetics, Inc. (3.02%), CONMED Co. (13.22%), Apollo Medical Holdings, Inc. (5.98%), Merus (5.86%), Denali Therapeutics Inc. (8.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Alibaba Group Holding Limited ($3.24 billion), Sempra ($2.36 billion), Digital Realty Trust, Inc. ($1.78 billion), Twilio Inc. ($1.67 billion), Alexandria Real Estate Equities, Inc. ($1.27 billion), Insulet Co. ($909.50 million), Guidewire Software, Inc. ($704.80 million), Zendesk, Inc. ($602.65 million), Medidata Solutions Inc ($560.77 million), and Prosperity Bancshares, Inc. ($437.13 million). View all of the most shorted stocks. What does it mean to sell short Genomic Health stock? Short selling GHDX is an investing strategy that aims to generate trading profit from Genomic Health as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genomic Health? A short squeeze for Genomic Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GHDX, which in turn drives the price of the stock up even further. How often is Genomic Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GHDX, twice per month. The most recent reporting period available is October, 15 2019. More Short Interest Resources from MarketBeat Related Companies: GH Short Squeeze RDNT Short Squeeze FTRE Short Squeeze VCYT Short Squeeze VRDN Short Squeeze FLGT Short Squeeze CNMD Short Squeeze AMEH Short Squeeze MRUS Short Squeeze DNLI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GHDX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeThe Next Nvidia?InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsUrgent alert: open this for a huge profit potentialTimothy Sykes